Carolyn Nessim profile picture

Contact Information

Carolyn Nessim, MD, MSc, FRCSC, FACS
613-737-8899 ext 71085
cnessim@toh.on.ca

Fax: 613-737-8659
www.carolynnessim.com

Publications

Selected Publications

Crawford, Nessim C, Weaver J, van Walraven C. Wait times for melanoma surgery: Is there an association with overall survival? Ann Surg Oncol 2017; 25(1): 265-270. doi. 10.1245/s10434-017-6146-2.    

Zhang Y, Cordeiro E, Seely J, Hefler J, Gravel D, Smylie J, Aro J, Nessim C. Radioactive Seed Localization vs. Wire-Guided Localization for non-palpable breast cancer: a Cost and OR efficiency analysis. Ann Surg Oncol 2017; 24(12): 3567-3573. doi. 10.1245/s10434-017-6084-z.    

Ambacher K, Ibrahim A, Nessim C.  Ensuring a Safe and Qualitative Diagnostic Biopsy for Retroperitoneal Sarcomas. UOJM 2017; 7(1): 45-48.

Lim R, Kielar AZ, El-Maraghi RH, Fraser MA, Nessim C and Thipphavong S. Multidisciplinary Retroperitoneal and Pelvic Soft Tissue Sarcoma Case Conferences: The Added Value Radiologists Can Provide. Current Oncology 2017; 24(3): 171-175. DOI: https://doi.org/10.3747/co.24.3478.

Head L, Nessim C, Boyd KU. Innovative model to optimize resource utilization and improve access to care for high-risk/BRCA+ breast cancer patients. Can J Surg 2016; 59(6):10.1503/cjs.001116 (Epub ahead of print). Can J Surg 2017; 60(1): 37-44.

Sulaiman A, Sulaiman B, Khouri L, McGarry S, Nessim C, Arnaout A, Addison CL, Dimitroulakos J, Wang L. Both bulk and CSC subpopulations in TNBC are susceptible to Wnt, HDAC and ERα co-inhibition. FEBS Lett. 2016; 590(24): 4606-4616. doi: 10.1002/1873-3468.12496. (Epub 2016 Dec 9.)

Trans-Atlantic Retroperitoneal Sarcoma Working Group (Gronchi A, Swallow C, Nessim C. et al.) Management of Recurrent Retroperitoneal Sarcoma (RPS) - A Consensus Approach from the Trans-Atlantic RPS Working Group. April 2016 In press Ann Surg Onc 2016

Tsvetkova E, Marginean C with Nessim C and Verma S. Gastrointestinal Stromal Tumor (GIST) – Paving the Way for Modern Oncology – Epidemiology, Diagnosis, Treatment. Oncology and Hematology Review 2015, In Print

Nessim C, Law C, McConnell Y, Shachar S, McKinnon G, Wright F. How often do Level III nodes bear melanoma metastases and does it affect patient outcomes? Ann Surg Oncol 2013 ; 20(6) :2056-64. doi : 10.1245/s10434-013-2880-2

Nessim C, Ferguson P, Gupta A, Catton C, Gladdy R. Retroperitoneal and Extremity Soft Tissue Sarcoma. Chapter in the Toronto Surgical Oncology Manual 1st edition, published in April 2012.

Nessim C, Govidarajan A, McCart A. Peritoneal Malignancies. Chapter in the Toronto Surgical Oncology Manual 1st edition, published in April 2012.

Nessim C, Rotstein L, Goldstein D, Sun A, Hogg D, McCready D, Ghazarian D. Princess Margaret Hospital: Melanoma Guidelines, PMH website, June 2012.


Peer-Reviewed Manuscripts Submitted

Gawad N, Ibrahim A, Duffy M, Raiche I, Nessim C. Identifying narcissistic traits in general surgery ?residency applicants: go with your gut. Submitted. Surgical Education. ·

Hasim MS, Nessim C, Villeneuve PJ, Vanderhyden BC and Dimitroulakos J. Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer. Submitted. International Journal of Cancer

Cooke C, MacDonald B, Nessim C, Singh S. Brushing up on barbeque tips: A case report of ingested metal brush bristles. Submitted. Abdominal Radiology

Sulaiman A, McGarry S, Li L, Jia D, Oi S, Addison C, Dimitroulakis J, Arnaout A, Nessim C, Yao Z, Ji G, Gadde S, Li X, Lisheng W.  Dual inhibition of Wnt and YAP signaling retards the growth of both mesenchymal and epithelial TNBC. Submitted. European Journal of Cancer

Zahr S, Mukhtar L, Dayekh K, Niknejad N, Hanson JEL, Johnson-Obaseki S, Odell MJ, Nessim C, Goss GD, Dimitroulakos J. Inhibition of GGTase1 enhances tarceva efficacy in squamous cell carcinoma cells: Potential novel combination therapeutic approach. Submitted, Oncotarget.

Yu A, Tran A, Nessim C, Ong M. Neoadjuvant therapy for stage III-IV melanoma: a systematic review of the literature and evaluation of future prospects, submitted to Journal of Surgical Oncology

Oral Presentations:

Raut CP, Callegaro D, Barretta F, Rutkowski P, Blay J-Y, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, de Paoli A, Pillarisetty V, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Miceli R, Gronchi A. Predicting Survival in patients undergoing resection for locoregionally recurrent retroperitoneal sarcoma: A study and nomogram from the Trans-Atlantic Sarcoma Working Group (TARPSWG).

Zhang Y, Cordeiro E, Seely J, Hefler J, Gravel D, Smylie J, Aro J, Nessim C. Radioactive Seed Localization vs. Wire-Guided Localization for non-palpable breast cancer: a Cost and OR efficiency analysis.

Berger-Richardson D, Nessim C, Burtenshaw S, Gladdy R, Gronchi A, Fiore M, Swallow C. Early and Late Complications of Percutaneous Biopsy of Retroperitoneal Masses at Three Tertiary Sarcoma Centers   

Ibrahim A, Bryanton M, Nessim C, Ong M. The Impact of Symptoms at Metastatic Recurrence on Treatment Outcomes for Patients under Surveillance for Early-Stage Melanoma

Crawford, Nessim C, Weaver J, van Walraven C. Association of wait times to surgical, medical and radiation therapies with overall survival in Ontarians with melanoma

Head L, Nessim C, Boyd KU. Innovative model to optimize resource utilization and improve access to care for high-risk/BRCA+ breast cancer patients.

Nessim C, Law C, McConnell Y, Shachar S, McKinnon G, Wright F. How often do Level III nodes bear melanoma metastases and does it affect patient outcomes?

Nessim C, Trop I, Robidoux A, Julian TB, Mamounas T, Boileau JF. Can MRI accurately identify which patients with operable breast cancer will have a pathologic complete response after neoadjuvant therapy?

Poster Presentations

Flaman A, Nessim C, Teo I, Gravel D, Purgina B. Utility of Core Needle Biopsy in Retroperitoneal Liposarcoma: A Fifteen Year Review. 

Nessim C, Carty K, El-Sayed S. IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa experience


PubMed Listings

For more publications use this PubMed ID link.